Plan now to participate in the Society of Toxicology (SOT) FutureTox III: Bridges for Translation—Transforming 21st Century Science into Risk Assessment and Regulatory Decision-Making conference. The abstracts for FutureTox III are due by August 15. Travel support is available for graduate students and postdoctoral scholars on a competitive basis.
The conference will be held November 19–20, 2015, at the Hilton Crystal City at Washington Reagan National Airport, Arlington, Virginia. This Contemporary Concepts in Toxicology (CCT) conference was developed by the Scientific Liaison Coalition and associated stakeholders and follows the well-received FutureTox II held in January 2014.
FutureTox III is focusing on building the high throughput risk assessment paradigm, taking the science of in vitro data and in silico models forward. Thus, the conference will explore the central question: What progress is being made to address challenges in applying and implementing the emerging “big data” toolbox for risk assessment and regulatory decision-making?
The overarching objectives of this meeting are toward:
- Advancing the cornerstones for high-throughput risk assessment through exploration and discussions with multiple stakeholders;
- Taking 21st century toxicity testing (TT21C) in vitro and in silico models forward while reducing reliance on animal testing; and
- Exploring progress and identifying challenges in implementing the emerging “big-data” toolbox for risk assessment and regulatory decision-making.
The conference will include plenary sessions by invited speakers, a poster session, and topical breakout groups. For more information, to submit an abstract, and to register, please visit the FutureTox III website.